AAE581

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for AAE581, covering 2011-11-02 to 2012-05-08. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of AAE581 in Postmenopausal Women With Osteoporosis [Phase 2]